Pavan Reddy, M.D., is the director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. He also is senior associate dean of Cancer Programs and holds an executive physician leadership role overseeing all oncology services, research and strategic growth at Baylor St. Luke’s Medical Center.
Dr. Reddy was born and raised in India. He earned his medical degree from Osmania University in Hyderabad in 1994 before coming to the United States, where he completed a residency in internal medicine at the University of Missouri in 1998. Following the completion of fellowships in hematology/oncology and bone and marrow transplantation at the University of Michigan, he joined the University of Michigan faculty in 2002. After serving as co-director of the Bone Marrow Transplant Program and the Hematologic Malignancies Program, Dr. Reddy served as the chief of the Division of Hematology/Oncology and Deputy Director of the University of Michigan Rogel Cancer Center. In September 2022, he joined Baylor as the director of the Duncan Cancer Center.
Dr. Reddy is the author or co-author of over 250 peer-reviewed journal articles and book chapters. He has received many honors and has been elected to honorary societies such as the American Society of Clinical Investigation, the Association of American Physicians and the American Clinical and Climatological Association. Dr. Reddy holds leadership roles in multiple scientific committees and has served in prominent leadership roles – such as past president of the American Society of Transplantation and Cellular Therapy – and on the scientific committees of the American Society of Hematology and several National Institutes of Health (NIH) panels. He is the deputy editor of JCI Insight and associate editor for the journals Hematologica, Transplantation and Cellular Therapy.
In the laboratory, Dr. Reddy focuses on the immunobiology of graft-versus-host disease (GVHD), a devastating immune response that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack has the transplant recipient’s body. Dr. Reddy hopes to translate the knowledge he gains through his research into powerful, lifesaving treatments for patients everywhere. His research has been continuously funded by the NIH with multiple grants for over 20 years.
Dr. Reddy and his wife Dr. Madhulata Reddy have two sons: Sidharth and Saahith.
